Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide survey | Synapse
March 3, 2026Open Access
Treatment strategies of AQP4-IgG positive neuromyelitis optica spectrum disorder and MOG antibody-associated disorder in Switzerland: a nationwide survey
Key Points
Neuromyelitis optica spectrum disorder treatment varies significantly among practitioners, highlighting personalized care strategies.
The survey revealed distinct preferences for treatment modes among 15 neurology centers, emphasizing individualized approaches.
Conducted as a nationwide survey across Switzerland, assessing responses from multiple treatment centers and specialists.
These findings highlight the need for standardized treatment protocols, potentially improving patient outcomes in autoimmune neurological disorders.